Pasar al contenido principal

IBIOSTROKE: IDENTIFICACION Y VALIDACION CLINICA DE BIOMARCADORES PARA LA EVOLUCION CLINICA POST-ICTUS.

AC19/00106

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Programación Conjunta Internacional
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Centro realización IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of the Gut Microbiota on Acute Ischemic Stroke Functional Outcomes at Three Months

  • Lledós, Miquel|||0000-0001-8832-789X
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Muiño, Elena|||0000-0001-5839-7328
  • Cullell, Natalia|||0000-0001-5118-1014
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Marín-Bueno, Rebeca|||0000-0002-0354-6602
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Guasch Jiménez, Marina|||0000-0001-6024-8348
  • Ezcurra Diaz, Garbiñe|||0000-0002-9511-3117
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Freijo, María del Mar
Background: Functional recovery from ischemic stroke (IS), the main cause of adult disability worldwide, is influenced by many factors, and a portion of interindividual variability remains unexplained. Methods: Observational study in a tertiary stroke centre of patients with IS analyzed using shotgun metagenomic sequencing (January 2020-March 2022). Functional outcomes were assessed according to modified Rankin Scale (mRS) scores 3-months post-IS, considering 0-2 favorable and 3-6 unfavorable. The causal relationship between several bacteria and post-IS outcomes was explored via two-sample Mendelian randomization (MR) analyses using Genome-Wide Association Analysis (GWAS) summary statistics. Results: Comparing 128 patients with favorable and unfavorable post-IS functional outcomes, β-diversity analysis showed a separation in microbial structure, and α-diversity measures revealed greater bacterial richness in the favorable outcomes group. Taxonomic profiling of the samples showed that a greater abundance of pathogenic bacteria (e.g., Pseudomonas, Finegoldia, Porphyromonas) was associated with an unfavorable outcome. Functional profiling of the samples revealed differences in the ethylbenzene degradation pathway and in 16S rRNA (uracil1498-N3)-methyltransferase. MR confirmed increased pyruvate levels to be causally associated with post-IS favorable outcomes (β = -0.50, 95% CI: -0.91, -0.10). Conclusions: Our study points to gut microbiota differences in patients with unfavorable versus favorable 3-month post-IS outcomes. Patients with unfavorable outcomes presented gut microbiota dysbiosis and alterations in multiple metabolic pathways. Trial Registration: This study was registered on 3 October 2021 with https://clinicaltrials.gov. Access number: NCT04795687.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Muiño, Elena|||0000-0001-5839-7328
  • Cullell, Natalia|||0000-0001-5118-1014
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Lledós, Miquel|||0000-0001-8832-789X
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Planas, Anna Maria|||0000-0002-6147-1880
  • DeDiego, Marta L.|||0000-0002-7888-7372
  • De Felipe, Alicia
  • Masjuan, Jaime|||0000-0003-1329-0943
  • García-Madrona, Sebastián
  • Segura, Tomás|||0000-0003-3625-0987
  • González-Villar, Esther
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Domínguez-Mayoral, Ana
  • Menéndez-Valladares, Paloma
  • Montaner, Joan|||0000-0003-4845-2279
  • Migeotte, Isabelle
  • Rahmouni, Souad
  • Darcis, Gilles|||0000-0001-8192-1351
  • Bernardo, D.|||0000-0002-2843-6696
  • Rojo, Silvia
  • Schulte, Eva C.|||0000-0003-3105-5672
  • Protzer, Ulrike|||0000-0002-9421-1911
  • Fricke, Lisa|||0000-0002-9268-0546
  • Winter, Christof|||0000-0002-0253-9056
  • Niemi, Mari E. K.
  • Cordioli, Mattia|||0000-0002-4872-0520
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
We aimed to analyse whether patients with ischaemic stroke (IS) occurring within eight days after the onset of COVID-19 (IS-COV) are associated with a specific aetiology of IS. We used SUPERGNOVA to identify genome regions that correlate between the IS-COV cohort (73 IS-COV cases vs. 701 population controls) and different aetiological subtypes. Polygenic risk scores (PRSs) for each subtype were generated and tested in the IS-COV cohort using PRSice-2 and PLINK to find genetic associations. Both analyses used the IS-COV cohort and GWAS from MEGASTROKE (67,162 stroke patients vs. 454,450 population controls), GIGASTROKE (110,182 vs. 1,503,898), and the NINDS Stroke Genetics Network (16,851 vs. 32,473). Three genomic regions were associated (p -value < 0.05) with large artery atherosclerosis (LAA) and cardioembolic stroke (CES). We found four loci targeting the genes PITX2 (rs10033464, IS-COV beta = 0.04, p -value = 2.3 × 10 -2, se = 0.02), previously associated with CES, HS6ST1 (rs4662630, IS-COV beta = -0.04, p -value = 1.3 × 10 -3, se = 0.01), TMEM132E (rs12941838 IS-COV beta = 0.05, p -value = 3.6 × 10 -4, se = 0.01), and RFFL (rs797989 IS-COV beta = 0.03, p -value = 1.0 × 10 -2, se = 0.01). A statistically significant PRS was observed for LAA. Our results suggest that IS-COV cases are genetically similar to LAA and CES subtypes. Larger cohorts are needed to assess if the genetic factors in IS-COV cases are shared with the general population or specific to viral infection.